Pinnacle Bancorp’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Pinnacle Bancorp’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-83	Closed	-$9K	–	815
2022 Q4	$9K	Sell	83 -109	-57%	-$9.05K	﹤0.01%	596
2022 Q3	$12K	Hold	192	–	–	0.01%	532
2022 Q2	$15K	Hold	192	–	–	0.01%	499
2022 Q1	$20K	Buy	192 +31	+19%	+$3.02K	0.01%	472
2021 Q4	$17K	Buy	161 +19	+13%	+$2.07K	0.01%	511
2021 Q3	$16K	Hold	142	–	–	0.01%	525
2021 Q2	$13K	Buy	+142	New	+$13.1K	0.01%	555

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Pinnacle Bancorp's HZNP Position: Q1 2023 in Review

Pinnacle Bancorp sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 83 shares — an estimated $9K sold.

Pinnacle Bancorp first reported a position in HZNP in Q2 2021 and held it in 7 quarters. The position peaked at $20K in Q1 2022. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

Pinnacle Bancorp reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Pinnacle Bancorp sold 83 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $9K.
Pinnacle Bancorp first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2021 and held it in 7 quarters.
Pinnacle Bancorp's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $20K in Q1 2022.
553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Pinnacle Bancorp's 13F filing for Q1 2023, filed 14 Apr 2023.